Recent News

• 03.25.2025 - 2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.25.2025 - 2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.11.2025 - 2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
• 03.11.2025 - 2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
• 03.05.2025 - 2025 TD Cowen Healthcare Conference
• 03.05.2025 - 2025 TD Cowen Healthcare Conference

Recent Filings

• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.17.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 03.14.2025 - SC14D9C Written communication relating to third party tender offer
• 03.13.2025 - SC TO-C Written communication relating to an issuer or third party
• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.13.2025 - SC14D9C Written communication relating to third party tender offer